The investigation of biomarkers for immune status and metabolic state, as well as host microbiota composition, in patients with ventricular arrhythmias before and after radiofrequency ablation, can provide new insights for specific and personalized treatment. This can help establish early prediction and prognosis models and provide a basis for clinically effective diagnosis and treatment.
Patients with ventricular premature beats, ventricular tachycardia, or ventricular fibrillation detected by regular surface twelve-lead electrocardiogram or Holter.
Age <18 or >80 years old;
Patients with autoimmune diseases or immune deficiencies, or those who have used immunosuppressive or immune modulating agents in the past 3 months;
Platelet count <100×10^9/L or functional platelet defects;
Congenital or acquired coagulation or bleeding disorders;
First Affiliated Hospital Xi'an Jiaotong University
Lead sponsor
521 Hospital of NORINCO Group
Collaborator
Shaanxi Provincial People's Hospital
Collaborator
Xiangyang Central Hospital
Collaborator
Henan Provincial People's Hospital
Collaborator